Profile
| Metric | Value |
|---|---|
| Full Name | Abbott Laboratories |
| Ticker | NYSE: ABT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | abbott.com |
| Employees | 114,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $124.64 | |
| Price, 1D Change | -1.02% | |
| Market Cap | $217B | |
| TTM Dividend Yield | 1.89% | |
| PE Ratio | 15.63 | |
| Beta | 0.23 | |
| Revenue | $42B | |
| Revenue, 1Y Change | +4.59% | |
| EPS | $7.64 | |
| EPS, 1Y Change | +134.32% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.59 | |
| Next Ex-Dividend | $0.63 | |
| Last Split | 5000:2399 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $7.64 | |
| EPS Estimate | $5.17 | |
| EPS Est. Change | -32.29% | |
| Revenue | $41.95B | |
| Revenue Estimate | $44.68B | |
| Revenue Est. Change | +6.50% | |
| Current Price | $124.64 | |
| Price Target | - | $145.00 |
| Price Tgt. Change | - | +16.34% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.44 | $3.26 | -26.59% | |
| $4.67 | $7.64 | +63.38% | |
| $5.17 | N/A | -32.29% | |
| $5.68 | N/A | -25.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $40.07B | $40.11B | +0.10% | |
| $41.99B | $41.95B | -0.09% | |
| $44.68B | N/A | +6.50% | |
| $48.23B | N/A | +14.98% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +10.98% | |
| Price, 3Y | +11.93% | |
| Market Cap, 1Y | +11.44% | |
| Market Cap, 3Y | +11.99% | |
| Revenue, 1Y | +4.59% | |
| Revenue, 3Y | -2.61% | |
| EPS, 1Y | +134.32% | |
| EPS, 3Y | +94.04% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $124.64 | |
| SMA 200 | $130.04 | |
| SMA 200 vs Price | +4.33% | |
| SMA 50 | $126.02 | |
| SMA 50 vs Price | +1.10% | |
| Beta | 0.23 | |
| ATR | $2.27 | |
| 14-Day RSI | 45.23 | |
| 10-Day Volatility | 15.26% | |
| 1-Year Volatility | 22.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.59 | |
| Upcoming | $0.63 | |
| Dividend Yield | 1.77% | |
| Total Dividend | $2.20 | |
| Dividends Paid | $3.84B | |
| Payout Ratio | 28.73% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $41.95B | |
| EPS | $7.64 | |
| Gross Profit | $21.33B | |
| Gross Margin | 50.83% | |
| Operating Profit | $6.85B | |
| Operating Margin | -32.83% | |
| Net Income | $13.35B | |
| Net Margin | 31.83% | |
| EBITDA | $10.07B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.32 | |
| Current Ratio | 1.67 | |
| Quick Ratio | 1.23 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 5.63 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 15.63 | |
| PS Ratio | 4.94 | |
| PB Ratio | 4.25 | |
| EV/EBITDA | 20.09 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $47.66B | |
| Cash & Equivalents | $7.97B | |
| Total Assets | $81.41B | |
| Current Assets | $23.66B | |
| Total Liabilities | $33.51B | |
| Current Liabilities | $14.16B | |
| Total Debt | $15.28B | |
| Short Term Debt | $1.75B | |
| Accounts Payable | $4.20B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $28.60B | |
| Operating Expenses | $14.47B | |
| Cost Of Goods Sold | $20.63B | |
| SG&A | $0.00 | |
| D&A | $3.22B | |
| Interest Expense | $0.00 | |
| Income Tax | -$6.39B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $8.56B | |
| CFI | -$2.34B | |
| CFF | -$5.40B | |
| Capex | $2.21B | |
| Free Cash Flow | $6.35B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Bernstein | → | |
| Barclays | → | |
| BTIG | → | |
| Barclays | → | |
| Wells Fargo | → | |
| Raymond James | → | |
| RBC Capital | → | |
| Evercore ISI Group | → | |
| BTIG | → | |
| Benchmark |
Analyst sentiment
Institutional ownership
Screeners with ABT
Data Sources & References
- ABT Official Website www.abbott.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ABT Profile on Yahoo Finance finance.yahoo.com/quote/ABT
- ABT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abt
FAQ
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is NYSE:ABT
Does Abbott Laboratories pay dividends?
Yes, Abbott Laboratories pays dividends. The last payment was $0.59, with an ex-dividend date on October 15, 2025
What sector is Abbott Laboratories in?
Abbott Laboratories is in the Healthcare sector
What industry is Abbott Laboratories in?
Abbott Laboratories is in the Medical Devices industry
What country is Abbott Laboratories based in?
Abbott Laboratories is headquartered in United States
When did Abbott Laboratories go public?
Abbott Laboratories initial public offering (IPO) was on March 17, 1980
Is Abbott Laboratories in the S&P 500?
Yes, Abbott Laboratories is included in the S&P 500 index
Is Abbott Laboratories in the NASDAQ 100?
No, Abbott Laboratories is not included in the NASDAQ 100 index
Is Abbott Laboratories in the Dow Jones?
No, Abbott Laboratories is not included in the Dow Jones index
When was Abbott Laboratories last earnings report?
Abbott Laboratories's most recent earnings report was on October 15, 2025
When does Abbott Laboratories report earnings?
The next expected earnings date for Abbott Laboratories is January 22, 2026